Published in Am J Hum Genet on October 01, 2009
The pathophysiology of fragile X (and what it teaches us about synapses). Annu Rev Neurosci (2012) 2.16
XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing. Am J Hum Genet (2013) 2.10
FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med (2012) 1.85
48,XXYY, 48,XXXY and 49,XXXXY syndromes: not just variants of Klinefelter syndrome. Acta Paediatr (2011) 1.84
Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics. J Clin Invest (2012) 1.42
Genetic studies in intellectual disability and related disorders. Nat Rev Genet (2015) 1.40
Fragile X syndrome: the FMR1 CGG repeat distribution among world populations. Ann Hum Genet (2011) 1.08
High-resolution methylation polymerase chain reaction for fragile X analysis: evidence for novel FMR1 methylation patterns undetected in Southern blot analyses. Genet Med (2011) 1.07
Analysis of FMRP mRNA target datasets reveals highly associated mRNAs mediated by G-quadruplex structures formed via clustered WGGA sequences. Hum Mol Genet (2014) 1.03
A simple, high-throughput assay for Fragile X expanded alleles using triple repeat primed PCR and capillary electrophoresis. J Mol Diagn (2010) 1.01
The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation. EMBO Mol Med (2013) 0.99
Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant. Psychopharmacology (Berl) (2012) 0.98
PAK in Alzheimer disease, Huntington disease and X-linked mental retardation. Cell Logist (2012) 0.97
Use of state administrative data sources to study adolescents and young adults with rare conditions. J Gen Intern Med (2014) 0.96
Social communication and theory of mind in boys with autism and fragile x syndrome. Front Psychol (2012) 0.96
The spectrum of the behavioral phenotype in boys and adolescents 47,XXY (Klinefelter syndrome). Pediatr Endocrinol Rev (2010) 0.95
Investigating word learning in fragile X syndrome: a fast-mapping study. J Autism Dev Disord (2013) 0.95
FMR1 intron 1 methylation predicts FMRP expression in blood of female carriers of expanded FMR1 alleles. J Mol Diagn (2011) 0.94
Modulation of the GABAergic pathway for the treatment of fragile X syndrome. Neuropsychiatr Dis Treat (2014) 0.94
Innovations in health and demographic surveillance systems to establish the causal impacts of HIV policies. Curr Opin HIV AIDS (2015) 0.93
Newborn screening and cascade testing for FMR1 mutations. Am J Med Genet A (2012) 0.91
The fragile x mental retardation syndrome 20 years after the FMR1 gene discovery: an expanding universe of knowledge. Clin Biochem Rev (2011) 0.91
G quadruplex RNA structures in PSD-95 mRNA: potential regulators of miR-125a seed binding site accessibility. RNA (2014) 0.90
Fragile X syndrome due to a missense mutation. Eur J Hum Genet (2014) 0.90
Novel methylation specific real-time PCR test for the diagnosis of Klinefelter syndrome. Asian J Androl (2014) 0.90
Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back. Neurotherapeutics (2015) 0.90
Epigenetics, autism spectrum, and neurodevelopmental disorders. Neurotherapeutics (2013) 0.89
Timing of diagnosis of 47,XXY and 48,XXYY: a survey of parent experiences. Am J Med Genet A (2013) 0.87
Fragile X syndrome. Colomb Med (Cali) (2014) 0.87
A comparison of family financial and employment impacts of fragile X syndrome, autism spectrum disorders, and intellectual disability. Res Dev Disabil (2014) 0.87
A novel methylation PCR that offers standardized determination of FMR1 methylation and CGG repeat length without southern blot analysis. J Mol Diagn (2013) 0.87
Screening criteria: the need to deal with new developments and ethical issues in newborn metabolic screening. J Community Genet (2012) 0.87
The role of hypogonadism in Klinefelter syndrome. Asian J Androl (2014) 0.86
The contribution of inhibitory interneurons to circuit dysfunction in Fragile X Syndrome. Front Cell Neurosci (2014) 0.85
The Genetics of Infertility: Current Status of the Field. Curr Genet Med Rep (2013) 0.85
The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment. J Neural Transm (Vienna) (2014) 0.85
Elevated levels of the vesicular monoamine transporter and a novel repetitive behavior in the Drosophila model of fragile X syndrome. PLoS One (2011) 0.83
Fragile X syndrome: mechanistic insights and therapeutic avenues regarding the role of potassium channels. Curr Opin Neurobiol (2012) 0.82
Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor/ataxia syndrome. Neurobiol Aging (2013) 0.82
Human pluripotent stem cell models of autism spectrum disorder: emerging frontiers, opportunities, and challenges towards neuronal networks in a dish. Psychopharmacology (Berl) (2014) 0.81
Perseveration in the connected speech of boys with Fragile X syndrome with and without autism spectrum disorder. Am J Intellect Dev Disabil (2012) 0.81
"How should I tell my child?" Disclosing the diagnosis of sex chromosome aneuploidies. J Genet Couns (2014) 0.81
In the Gray Zone in the Fragile X Gene: What are the Key Unanswered Clinical and Biological Questions? Tremor Other Hyperkinet Mov (N Y) (2014) 0.81
Testing the FMR1 promoter for mosaicism in DNA methylation among CpG sites, strands, and cells in FMR1-expressing males with fragile X syndrome. PLoS One (2011) 0.81
Accumulated common variants in the broader fragile X gene family modulate autistic phenotypes. EMBO Mol Med (2015) 0.80
Cognitive, environmental, and linguistic predictors of syntax in fragile X syndrome and Down syndrome. J Speech Lang Hear Res (2012) 0.80
Parent-delivered touchscreen intervention for children with fragile X syndrome. Intractable Rare Dis Res (2014) 0.78
Offering fragile X syndrome carrier screening: a prospective mixed-methods observational study comparing carrier screening of pregnant and non-pregnant women in the general population. BMJ Open (2013) 0.78
A common STEP in the synaptic pathology of diverse neuropsychiatric disorders. Yale J Biol Med (2012) 0.78
Shared functional defect in IP3R-mediated calcium signaling in diverse monogenic autism syndromes. Transl Psychiatry (2015) 0.78
Anxiety disorders in fragile X premutation carriers: Preliminary characterization of probands and non-probands. Intractable Rare Dis Res (2015) 0.78
Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study. J Neurodev Disord (2013) 0.77
Testis Development and Fertility Potential in Boys with Klinefelter Syndrome. Endocrinol Metab Clin North Am (2015) 0.77
Fragile X Syndrome: Scientific Background and Screening Technologies. J Mol Diagn (2015) 0.77
Human pluripotent stem cell models of Fragile X syndrome. Mol Cell Neurosci (2015) 0.77
Fragile X protein in newborn dried blood spots. BMC Med Genet (2014) 0.77
Identification of a male with fragile X syndrome through newborn screening. Intractable Rare Dis Res (2015) 0.76
Synaptic vesicle dynamic changes in a model of fragile X. Mol Autism (2016) 0.76
Derivation of integration-free iPSCs from a Klinefelter syndrome patient. Reprod Med Biol (2015) 0.76
Single-Nucleotide Mutations in FMR1 Reveal Novel Functions and Regulatory Mechanisms of the Fragile X Syndrome Protein FMRP. J Exp Neurosci (2015) 0.76
Defining the role of the CGGBP1 protein in FMR1 gene expression. Eur J Hum Genet (2015) 0.76
Finding FMR1 mosaicism in Fragile X syndrome. Expert Rev Mol Diagn (2016) 0.76
Association between macroorchidism and intelligence in FMR1 premutation carriers. Am J Med Genet A (2014) 0.76
Diagnosis of fragile X syndrome: a qualitative study of African American families. J Genet Couns (2011) 0.76
Functional magnetic resonance imaging in awake transgenic fragile X rats: evidence of dysregulation in reward processing in the mesolimbic/habenular neural circuit. Transl Psychiatry (2016) 0.75
Towards a Better Molecular Diagnosis of FMR1-Related Disorders-A Multiyear Experience from a Reference Lab. Genes (Basel) (2016) 0.75
Autism Spectrum Disorder in Males with Sex Chromosome Aneuploidy: XXY/Klinefelter Syndrome, XYY, and XXYY. J Dev Behav Pediatr (2017) 0.75
Molecular Correlates and Recent Advancements in the Diagnosis and Screening of FMR1-Related Disorders. Genes (Basel) (2016) 0.75
Clinical and Technical Overview of Preimplantation Genetic Diagnosis for Fragile X Syndrome: Experience at the University Hospital Virgen del Rocio in Spain. Biomed Res Int (2015) 0.75
Progress toward therapeutic potential for AFQ056 in Fragile X syndrome. J Exp Pharmacol (2013) 0.75
Reduced vagal tone in women with the FMR1 premutation is associated with FMR1 mRNA but not depression or anxiety. J Neurodev Disord (2017) 0.75
DNA repair/replication transcripts are down regulated in patients with Fragile X Syndrome. BMC Res Notes (2013) 0.75
Most Martin-Bell syndrome (FMR1-related disorder) Venezuelan patients did not show CGG expansion but instead display genetic heterogeneity. J Hum Genet (2016) 0.75
The PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia. Mol Cell Ther (2016) 0.75
Cognitive Aspects of Fragile X syndrome. Wiley Interdiscip Rev Cogn Sci (2014) 0.75
Autism Spectrum Disorder Symptoms in Infants with Fragile X Syndrome: A Prospective Case Series. J Autism Dev Disord (2017) 0.75
A novel link between FMR gene and the JNK pathway provides clues to possible role in malignant pleural mesothelioma. FEBS Open Bio (2015) 0.75
Establishment of Reporter Lines for Detecting Fragile X Mental Retardation (FMR1) Gene Reactivation in Human Neural Cells. Stem Cells (2016) 0.75
Molecular diagnostic testing for Klinefelter syndrome and other male sex chromosome aneuploidies. Int J Pediatr Endocrinol (2012) 0.75
Emergency department and inpatient hospitalizations for young people with fragile X syndrome. Am J Intellect Dev Disabil (2015) 0.75
eIF4E/Fmr1 double mutant mice display cognitive impairment in addition to ASD-like behaviors. Neurobiol Dis (2015) 0.75
Advanced technologies for the molecular diagnosis of fragile X syndrome. Expert Rev Mol Diagn (2015) 0.75
Brain structure and intragenic DNA methylation are correlated, and predict executive dysfunction in fragile X premutation females. Transl Psychiatry (2016) 0.75
Advances in the Interdisciplinary Care of Children with Klinefelter Syndrome. Adv Pediatr (2016) 0.75
FORWARD: A Registry and Longitudinal Clinical Database to Study Fragile X Syndrome. Pediatrics (2017) 0.75
Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment. Pediatrics (2017) 0.75
Recent advances in assays for the fragile X-related disorders. Hum Genet (2017) 0.75
Diverse Profiles of Anxiety Related Disorders in Fragile X, Cornelia de Lange and Rubinstein-Taybi Syndromes. J Autism Dev Disord (2017) 0.75
Noncomprehension Signaling in Males and Females With Fragile X Syndrome. J Speech Lang Hear Res (2017) 0.75
Effects of a social stimulus on gene expression in a mouse model of fragile X syndrome. Mol Autism (2017) 0.75
Don't miss patients with atypical FMR1 mutations: dysmorphism and clinical features in a boy with a partially methylated FMR1 full mutation. Eur J Pediatr (2014) 0.75
A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A (1992) 29.51
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell (1991) 17.00
Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell (1991) 12.27
Absence of expression of the FMR-1 gene in fragile X syndrome. Cell (1991) 7.04
Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology (2001) 6.55
DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet (1992) 4.22
FMR1 and the fragile X syndrome: human genome epidemiology review. Genet Med (2001) 3.84
Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. Am J Med Genet (1999) 3.82
A cytogenetic survey of 14,069 newborn infants. I. Incidence of chromosome abnormalities. Clin Genet (1975) 3.81
Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet (1991) 3.81
A cytogenetic survey of 11,680 newborn infants. Ann Hum Genet (1974) 3.80
A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J Mol Diagn (2007) 3.80
Prevalence of fragile X syndrome. Am J Med Genet (1996) 3.19
Advances in the treatment of fragile X syndrome. Pediatrics (2009) 3.10
Chromosome aberrations in 2159 consecutive newborn babies. N Engl J Med (1969) 3.03
RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron (2003) 2.81
47,XXY (Klinefelter syndrome) and 47,XYY: estimated rates of and indication for postnatal diagnosis with implications for prenatal counselling. Prenat Diagn (1997) 2.77
Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat Genet (1999) 2.59
Expanded newborn screening for biochemical disorders: the effect of a false-positive result. Pediatrics (2006) 2.35
Methylation-specific PCR simplifies imprinting analysis. Nat Genet (1997) 2.33
Is the prevalence of Klinefelter syndrome increasing? Eur J Hum Genet (2007) 2.10
Prevalence of the fragile X syndrome in African-Americans. Am J Med Genet (2002) 2.07
The frequency of the fragile X chromosome among schoolchildren in Coventry. J Med Genet (1986) 2.06
Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. Nat Chem Biol (2008) 2.04
Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population. J Mol Diagn (2009) 1.94
Klinefelter syndrome and other sex chromosomal aneuploidies. Orphanet J Rare Dis (2006) 1.93
A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases. Am J Hum Genet (1994) 1.84
Preventive screening for the fragile X syndrome. N Engl J Med (1986) 1.76
A G-band study of chromosomes in liveborn infants. Ann Hum Genet (1980) 1.72
Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1. Hum Mol Genet (1997) 1.70
Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome. Am J Hum Genet (2002) 1.59
FRAXA and FRAXE: the results of a five year survey. J Med Genet (2000) 1.50
The National Down Syndrome Project: design and implementation. Public Health Rep (2007) 1.35
Discovering fragile X syndrome: family experiences and perceptions. Pediatrics (2003) 1.34
Chromosome analysis on 930 consecutive newborn children using quinacrine fluorescent banding technique. Hum Genet (1976) 1.33
Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues. Pediatrics (2008) 1.31
Cytogenetic screening of a new-born population. Clin Genet (1982) 1.27
Fragile X syndrome detection in newborns-pilot study. Genet Med (2008) 1.12
Psychiatric disorders associated with fragile X in the young female. Pediatrics (1993) 1.09
Incidence of fragile X in 5,000 consecutive newborn males. Genet Test (2003) 1.09
Incidence of chromosome abnormalities in newborn children. Comparison between incidences in 1969-1974 and 1980-1982 in the same area. Hum Genet (1982) 1.06
Methylation-specific multiplex ligation-dependent probe amplification enables a rapid and reliable distinction between male FMR1 premutation and full-mutation alleles. J Mol Diagn (2008) 1.05
Development of a novel, accurate, automated, rapid, high-throughput technique suitable for population-based carrier screening for Fragile X syndrome. Genet Med (2007) 1.05
Family experiences and factors associated with the diagnosis of fragile X syndrome. J Dev Behav Pediatr (2000) 1.05
Nuclease sensitivity of permeabilized cells confirms altered chromatin formation at the fragile X locus. Somat Cell Mol Genet (1996) 0.96
A cytogenetic survey of 14,835 consecutive liveborns. Jinrui Idengaku Zasshi (1991) 0.95
Molecular genetic testing in pediatric practice: A subject review. Committee on Genetics. Pediatrics (2000) 0.86
Diagnosis of fragile-X syndrome: the experiences of parents. J Intellect Disabil Res (1999) 0.86
X inactivation of the FMR1 fragile X mental retardation gene. J Med Genet (1995) 0.84
[Chromosome anomalies among newborn infants in Lithuania]. Genetika (1978) 0.78
The mGluR theory of fragile X mental retardation. Trends Neurosci (2004) 8.88
Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci U S A (2002) 6.45
Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron (2008) 6.26
Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci (2004) 4.69
The FMR1 premutation and reproduction. Fertil Steril (2006) 3.85
A decade of molecular studies of fragile X syndrome. Annu Rev Neurosci (2002) 3.54
An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genet Med (2011) 3.51
Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. Neuron (2007) 3.17
The pathophysiology of fragile x syndrome. Annu Rev Genomics Hum Genet (2007) 2.85
RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron (2003) 2.81
Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet (2003) 2.71
Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am J Hum Genet (2010) 2.70
Phosphorylation influences the translation state of FMRP-associated polyribosomes. Hum Mol Genet (2003) 2.66
RNA and microRNAs in fragile X mental retardation. Nat Cell Biol (2004) 2.63
Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum Mol Genet (2007) 2.55
Age-associated DNA methylation in pediatric populations. Genome Res (2012) 2.53
Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet (2011) 2.46
Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annu Rev Pathol (2011) 2.39
Microdeletions of 3q29 confer high risk for schizophrenia. Am J Hum Genet (2010) 2.38
The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Proc Natl Acad Sci U S A (2004) 2.34
Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling. Mol Cell (2011) 2.27
Replication stress induces tumor-like microdeletions in FHIT/FRA3B. Proc Natl Acad Sci U S A (2007) 2.27
Genetic analysis of variation in human meiotic recombination. PLoS Genet (2009) 2.11
Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors. Proc Natl Acad Sci U S A (2007) 2.10
Prevalence of the fragile X syndrome in African-Americans. Am J Med Genet (2002) 2.07
Replication stress induces genome-wide copy number changes in human cells that resemble polymorphic and pathogenic variants. Am J Hum Genet (2009) 2.07
Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. Nat Chem Biol (2008) 2.04
FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A. J Neurosci (2007) 2.02
Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome. J Neurosci (2010) 1.89
A study of the distributional characteristics of FMR1 transcript levels in 238 individuals. Hum Genet (2004) 1.88
S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade. J Biol Chem (2008) 1.87
Local RNA translation at the synapse and in disease. J Neurosci (2011) 1.83
Fragile X syndrome. Eur J Hum Genet (2008) 1.81
Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen. Sci Transl Med (2012) 1.72
Transcription, translation and fragile X syndrome. Curr Opin Genet Dev (2006) 1.72
New insights into fragile X syndrome: from molecules to neurobehaviors. Trends Biochem Sci (2003) 1.68
New insights into human nondisjunction of chromosome 21 in oocytes. PLoS Genet (2008) 1.68
Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population. Proc Natl Acad Sci U S A (2010) 1.64
Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome. Am J Hum Genet (2002) 1.59
Genetic modifiers predisposing to congenital heart disease in the sensitized Down syndrome population. Circ Cardiovasc Genet (2012) 1.57
A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet (2012) 1.52
Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration. Nat Neurosci (2007) 1.46
Microarray-based mutation detection in the dystrophin gene. Hum Mutat (2008) 1.39
Physiological identification of human transcripts translationally regulated by a specific microRNA. Hum Mol Genet (2005) 1.39
Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project. Genet Med (2008) 1.36
The National Down Syndrome Project: design and implementation. Public Health Rep (2007) 1.35
Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DS. J Med Genet (2012) 1.33
No evidence for a difference in neuropsychological profile among carriers and noncarriers of the FMR1 premutation in adults under the age of 50. Am J Hum Genet (2008) 1.29
Subtelomeric hotspots of aberrant 5-hydroxymethylcytosine-mediated epigenetic modifications during reprogramming to pluripotency. Nat Cell Biol (2013) 1.27
The unstable repeats--three evolving faces of neurological disease. Neuron (2013) 1.26
Paternally transmitted FMR1 alleles are less stable than maternally transmitted alleles in the common and intermediate size range. Am J Hum Genet (2002) 1.25
Association between maternal age and meiotic recombination for trisomy 21. Am J Hum Genet (2004) 1.23
New perspectives on the biology of fragile X syndrome. Curr Opin Genet Dev (2012) 1.23
Fragile X analysis of 1112 prenatal samples from 1991 to 2010. Prenat Diagn (2011) 1.23
Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome Projects. Hum Genet (2008) 1.22
A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels. Blood (2007) 1.22
Mosaic FMR1 deletion causes fragile X syndrome and can lead to molecular misdiagnosis: a case report and review of the literature. Am J Med Genet A (2008) 1.21
Genome-wide DNA hydroxymethylation changes are associated with neurodevelopmental genes in the developing human cerebellum. Hum Mol Genet (2012) 1.21
Examination of FMR1 transcript and protein levels among 74 premutation carriers. J Hum Genet (2009) 1.20
Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles. Am J Med Genet A (2013) 1.19
Identification of novel FMR1 variants by massively parallel sequencing in developmentally delayed males. Am J Med Genet A (2010) 1.16
Neurogenetics: advancing the "next-generation" of brain research. Neuron (2010) 1.16
Development and validation of the Arizona Cognitive Test Battery for Down syndrome. J Neurodev Disord (2010) 1.15
Fragile X protein functions with lgl and the par complex in flies and mice. Dev Cell (2005) 1.14
The fragile X mental retardation protein, FMRP, recognizes G-quartets. Ment Retard Dev Disabil Res Rev (2004) 1.14
Variation in folate pathway genes contributes to risk of congenital heart defects among individuals with Down syndrome. Genet Epidemiol (2010) 1.14
Investigation of phenotypes associated with mood and anxiety among male and female fragile X premutation carriers. Behav Genet (2008) 1.12
Consensus characterization of 16 FMR1 reference materials: a consortium study. J Mol Diagn (2007) 1.09
Clinical significance of tri-nucleotide repeats in Fragile X testing: a clarification of American College of Medical Genetics guidelines. Genet Med (2008) 1.08
CRELD1 mutations contribute to the occurrence of cardiac atrioventricular septal defects in Down syndrome. Am J Med Genet A (2006) 1.07
New clinical findings in the fragile X-associated tremor ataxia syndrome (FXTAS). Neurogenetics (2011) 1.06
Is there evidence for neuropsychological and neurobehavioral phenotypes among adults without FXTAS who carry the FMR1 premutation? A review of current literature. Genet Med (2009) 1.04
Linkage disequilibrium mapping in trisomic populations: analytical approaches and an application to congenital heart defects in Down syndrome. Genet Epidemiol (2004) 1.03
Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice. Hum Mol Genet (2012) 1.03
Array-based assay detects genome-wide 5-mC and 5-hmC in the brains of humans, non-human primates, and mice. BMC Genomics (2014) 1.03
An excess of deleterious variants in VEGF-A pathway genes in Down-syndrome-associated atrioventricular septal defects. Am J Hum Genet (2012) 1.01
Fragile X syndrome: an update and review for the primary pediatrician. Clin Pediatr (Phila) (2005) 1.01
Genetics. Genetic control of hotspots. Science (2010) 1.01
Altered patterns of multiple recombinant events are associated with nondisjunction of chromosome 21. Hum Genet (2011) 0.99
Argonaute2 is essential for mammalian gastrulation and proper mesoderm formation. PLoS Genet (2007) 0.99
Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity. Genet Epidemiol (2008) 0.99
Genome-wide analysis validates aberrant methylation in fragile X syndrome is specific to the FMR1 locus. BMC Med Genet (2013) 0.97
Gene expression profiles in a transgenic animal model of fragile X syndrome. Neurobiol Dis (2002) 0.96
The FMR1 premutation and attention-deficit hyperactivity disorder (ADHD): evidence for a complex inheritance. Behav Genet (2011) 0.96
Decisions to participate in fragile X and other genomics-related research: Native American and African American voices. J Cult Divers (2009) 0.94
Women's attitudes toward testing for fragile X carrier status: a qualitative analysis. J Genet Couns (2005) 0.93
Smarter clustering methods for SNP genotype calling. Bioinformatics (2008) 0.93
Array-based FMR1 sequencing and deletion analysis in patients with a fragile X syndrome-like phenotype. PLoS One (2010) 0.93
Neurodevelopmental outcomes in children with Down syndrome and congenital heart defects. Am J Med Genet A (2011) 0.92
Preconception folic acid supplementation and risk for chromosome 21 nondisjunction: a report from the National Down Syndrome Project. Am J Med Genet A (2013) 0.90
Depression and anxiety symptoms among women who carry the FMR1 premutation: impact of raising a child with fragile X syndrome is moderated by CRHR1 polymorphisms. Am J Med Genet B Neuropsychiatr Genet (2012) 0.89
Investigation of factors associated with paternal nondisjunction of chromosome 21. Am J Med Genet A (2009) 0.89
Modulating huntingtin half-life alters polyglutamine-dependent aggregate formation and cell toxicity. J Neurochem (2004) 0.89
Predictors and risk model development for menopausal age in fragile X premutation carriers. Genet Med (2011) 0.88
Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiency. Ann N Y Acad Sci (2008) 0.88
Lack of maternal folic acid supplementation is associated with heart defects in Down syndrome: a report from the National Down Syndrome Project. Birth Defects Res A Clin Mol Teratol (2011) 0.87
Neuroscience: fragile dopamine. Nature (2008) 0.87
A trisomic transmission disequilibrium test. Genet Epidemiol (2004) 0.86
Newborn, carrier, and early childhood screening recommendations for fragile X. Pediatrics (2012) 0.85